How is the Climb Bio Inc. today?

The Climb Bio Inc. today is trading in the down by -1.57% at 1.25.

What is Climb Bio Inc. Annual Net Profit?

Climb Bio Inc. Annual Net Profit fell 110.42% in the last year to $73.9 M. Its sector's average net profit growth for the last fiscal year was -33.01%.

What is Climb Bio Inc. Price to Earning Ratio?

Climb Bio Inc. Price to Earning Ratio is -1.14, which is negative.

What is Climb Bio Inc. Stock Price?

Climb Bio Inc. Stock Price fell 87.7% and underperformed its sector by 96.6% in the past year.

What is Climb Bio Inc. Quarterly Net profit?

Climb Bio Inc. Quarterly Net profit fell 131.15% YoY to $8.42 M. Its sector's average net profit growth YoY for the quarter was -31.14%.

What is Climb Bio Inc. Debt to Equity Ratio?

Climb Bio Inc. Debt to Equity Ratio is zero as the company is debt-free.

What is Climb Bio Inc. Return on Equity(ROE)?

Climb Bio Inc. Return on Equity(ROE) for the last financial year was -46.26%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Climb Bio Inc. Mutual Fund Holding?

Climb Bio Inc. Mutual Fund Holding decreased by 0.44% in the last quarter to 8.33.

What is Climb Bio Inc. Institutional Holding?

Climb Bio Inc. Institutional Holding increased by 0.79% in the last quarter to 85.44.

Climb Bio Inc. XNAS: CLYM

Climb Bio Inc. Live Share Price Today, Share Analysis and Chart

Name: Climb Bio Inc.: Is Infosys Ltd. worth buying?
Item: Climb Bio Inc.
Rating: 1.06041675
Author: Trendlyne DVM scores

about

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the pote...

1.25 -0.02 (-1.57%)

88.49% Fall from 52W High

124.3K XNAS Volume

XNAS 05 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Climb Bio Inc. is on 15 May 2025 for the purpose of Eliem Therapeutics Inc First Quarter Earnings Results for 2025 See details

Not Eligible

-

Expensive Valuation

14.7 / 100

Technically Bearish

27.8 / 100

No estimates available

Climb Bio Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Climb Bio Inc. FAQ

How is Climb Bio Inc. today?

Climb Bio Inc. today is trading in the red, and is down by -1.57% at 1.25.

How has Climb Bio Inc. performed historically?

Climb Bio Inc. is currently trading down -1.57% on an intraday basis. In the past week the stock fell -1.57%. stock has been down -33.16% in the past quarter and fell -87.70% in the past year. You can view this in the overview section.